CAS 211914-50-0

N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride

Description:

N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride is a complex organic compound characterized by its multi-functional structure, which includes a benzimidazole moiety, an amino group, and a pyridine ring. This compound is typically classified as a pharmaceutical intermediate or a potential drug candidate due to its intricate arrangement of functional groups that may exhibit biological activity. The presence of the benzimidazole structure often correlates with various pharmacological properties, including anti-cancer and anti-inflammatory effects. The hydrochloride salt form enhances its solubility in aqueous solutions, which is beneficial for biological assays and potential therapeutic applications. Additionally, the compound's molecular structure suggests it may interact with specific biological targets, making it of interest in medicinal chemistry. However, detailed studies on its pharmacodynamics, pharmacokinetics, and toxicity are essential for understanding its full potential and safety profile in therapeutic contexts.

Formula: C₂₇H₂₉N₇O₃HCl

Synonyms:

• Alanine,N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl] -1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, monohydrochloride
• ethyl 3-(2-(((4-carbamimidoylphenyl) amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride
• N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl esterhydrochloride
• N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-Alanine, ethyl ester, HCl (1:1)

Dabigatran ethyl ester hydrochloride

CAS: 211914-50-0

Dabigatran prevents blood clots, inhibiting NQO2 and thrombin with IC50 0.8 μM.

Formula: C₂₇H₃₀ClN₇O₃

Purity: 99.65%

Color and Shape: Solid

Molecular weight: 536.03

Ref: TM-T10951

Dabigatran Etexilate Impurity 73 Hydrochloride

CAS: 211914-50-0

Dabigatran Etexilate Impurity 73 Hydrochloride

Purity: 96%

Molecular weight: 536.03g/mol

Ref: 54-OR1024660

Dabigatran ethyl ester hydrochloride

CAS: 211914-50-0

Dabigatran ethyl ester hydrochloride

Purity: ≥98%

Molecular weight: 536.03g/mol

Ref: 54-BUP06637

Dabigatran Impurity 73 HCl

CAS: 211914-50-0

Formula: C₂₇H₂₉N₇O₃·HCl

Color and Shape: White To Off-White Solid

Molecular weight: 499.58 36.46

Ref: 4Z-D-5921

Dabigatran Ethyl Ester Hydrochloride Salt

Controlled Product

CAS: 211914-50-0

Stability Hygroscopic Applications Dabigatran Ethyl Ester Hydrochloride Salt is a derivative of Dabigatran (D100090), acting as nonpeptide, direct thrombin inhibitor. Antithrombotic. References Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002), Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002), Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005),

Formula: C₂₇H₂₉N₇O₃·ClH

Color and Shape: Light Yellow

Molecular weight: 536.03

Ref: TR-D100135

Dabigatran Ethyl Ester

CAS: 211914-50-0

Formula: C₂₇H₂₉N₇O₃HCl

Molecular weight: 499.6 : 36.46

Ref: ST-EA-CP-D5010

Dabigatran-13C6 Ethyl Ester Hydrochloride Salt

Controlled Product

CAS: 211914-50-0

Formula: C₂₁C₆H₂₉N₇O₃•x(HCl)

Color and Shape: Neat

Molecular weight: 505.52 + x(36.46)

Ref: TR-D100137

Dabigatran ethyl ester hydrochloride

CAS: 211914-50-0

Please enquire for more information about Dabigatran ethyl ester hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formula: C₂₇H₃₀ClN₇O₃

Purity: Min. 95%

Molecular weight: 536.03 g/mol

Ref: 3D-LIA91450